Nalaganje...
Eplerenone: A New Aldosterone Receptor Antagonist—Are the FDA's Restrictions Appropriate?
Eplerenone is a new aldosterone receptor antagonist that will be used in the treatment of hypertension. Like spironolactone, it is a compound that can be associated with the development of hyperkalemia. Therefore, the same prescription considerations that are applied to spironolactone should be dire...
Shranjeno v:
| izdano v: | J Clin Hypertens (Greenwich) |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Le Jacq Communications, Inc.
2008
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8099290/ https://ncbi.nlm.nih.gov/pubmed/12461313 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1524-6175.2002.01510.x |
| Oznake: |
Označite
Brez oznak, prvi označite!
|